Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Membranous Nephropathy”

54 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 54 results

Not applicableUnknownNCT05532111
What this trial is testing

Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial

Who this might be right for
Efficacy and Safety
RenJi Hospital 60
Not applicableLooking for participantsNCT06893328
What this trial is testing

A Real World Study About PMN

Who this might be right for
Primary Membranous Nephropathy
Wei Chen 200
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Large-scale testing (Phase 3)Study completedNCT01955187
What this trial is testing

Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

Who this might be right for
MEMBRANOUS NEPHROPATHY
Hospital Universitario 12 de Octubre 86
Early research (Phase 1)Not Yet RecruitingNCT07234474
What this trial is testing

A Phase I Study of YK012 in Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Excyte Biopharma Ltd 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07765537
What this trial is testing

A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shenzhen Fosun Kairos Biotechnology Co., Ltd. 55
Testing effectiveness (Phase 2)Ended earlyNCT04652570
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Tenet Medicines 6
Early research (Phase 1)Looking for participantsNCT05668403
What this trial is testing

A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd 52
Large-scale testing (Phase 3)WithdrawnNCT06120673
What this trial is testing

REmission in Membranous Nephropathy International Trial (REMIT)

Who this might be right for
Primary Membranous Nephropathy
The University of Queensland
Large-scale testing (Phase 3)Looking for participantsNCT05696613
What this trial is testing

SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Cerium Pharmaceuticals, Inc. 148
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07029139
What this trial is testing

Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Shanghai JMT-Bio Inc. 156
Large-scale testing (Phase 3)Active Not RecruitingNCT04629248
What this trial is testing

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
Hoffmann-La Roche 142
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06642909
What this trial is testing

A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous Nephropathy

Who this might be right for
Primary Membranous Nephropathy
BioRay Pharmaceutical Co., Ltd. 135
Testing effectiveness (Phase 2)Active Not RecruitingNCT05732402
What this trial is testing

An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases

Who this might be right for
Lupus NephritisImmunoglobulin A NephropathyMembranous Nephropathy+1 more
Alpine Immune Sciences, Inc. 72
Large-scale testing (Phase 3)Looking for participantsNCT06470191
What this trial is testing

A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.

Who this might be right for
Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd 216
Very early researchNot Yet RecruitingNCT06690359
What this trial is testing

IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy Patients

Who this might be right for
IgA NephropathyMembranous Nephropathy
Beijing Immunochina Medical Science & Technology Co., Ltd. 12
Early research (Phase 1)Study completedNCT05800873
What this trial is testing

Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001

Who this might be right for
Primary Membranous Nephropathy
Everest Medicines (China) Co.,Ltd. 31
Not applicableUnknownNCT05679336
What this trial is testing

Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous Nephropathy

Who this might be right for
Membranous Nephropathy - PLA2R Induced
St. Petersburg State Pavlov Medical University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06983028
What this trial is testing

Atacicept in Multiple Glomerular Diseases

Who this might be right for
pMNIgANNephrotic Syndrome+2 more
Vera Therapeutics, Inc. 250
Next Page